"Beneficial" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
Some believe that ACE-I/ARB use is beneficial in treating SARS-CoV-2 infections beneficial because the relative amount of Ang II is decreased. While ACE2 expression may increase, the anti-inflammatory and anti-oxidant properties of Ang II could be helpful in mitigating or preventing acute lung injury.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
"Harmful" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
"Beneficial" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
Chronic ACE-I/ARB Use Is Associated with Acute Kidney Injury (AKI) in Severe COVID-19 Patients
Rationale in Using ACE Inhibitors (ACE-Is) to Treat or Prevent COVID-19
Controversy of Using ACE Inhibitors (ACE-Is) for Blood Pressure Management in COVID-19
"Beneficial" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
"Harmful" ACE-I/ARB Hypothesis in Treating SARS-CoV-2 Infection
Chronic ACE-I/ARB Use Is Associated with Acute Kidney Injury (AKI) in Severe COVID-19 Patients